In the Norwegian Atherosclerosis and Childhood Diabetes prospective study, the analysis of TNF-α and IL-18 levels, among others, showed that the early, low-grade inflammation present in young people with T1D five years after diagnosis persists through ten years of disease, with moderate changes in most inflammatory markers over time [22]. This evidence concerns the gene IL18 and type 1 diabetes mellitus.